Single-Dose Otic Gel for Extended Ear Canal Retention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for fungal ear infections, such as otitis externa, require multiple applications over an extended period, are inconvenient, and often fail to eradicate a broad spectrum of fungal and bacterial infections due to poor adherence to the ear canal and patient non-compliance, with existing formulations having limited efficacy.
Innovation Solution
A single-dose otic formulation containing marbofloxacin, terbinafine, and dexamethasone or clotrimazole in a thickened base that maintains viscosity within the ear canal for several days, ensuring continuous release of active ingredients to treat fungal and bacterial infections and inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If liquid ear drops are used to treat fungal ear infections, then the treatment can be easily administered, but the liquid egresses from the ear canal rapidly and cannot reach all infected areas, especially in the upper half
Solution Approach 1:
The patent changes the physical parameter of viscosity by incorporating a thickening agent (carboxymethylcellulose sodium) to transform the liquid formulation into a semi-solid gel. This increases the retention time in the ear canal from minutes to hours, allowing the medication to remain in contact with infected areas including the upper half of the ear canal that liquid drops cannot reach.
2Duration of action of moving object
If creams and ointments are used to treat fungal ear infections, then they remain in the ear canal longer, but they must be removed by the ENT physician after treatment
Solution Approach 1:
The patent uses a semi-solid gel formulation with controlled viscosity that balances retention and removal properties. The gel maintains its structure long enough to provide sustained treatment (unlike liquid drops) but remains soft and pliable enough to be easily expelled or cleaned by the patient without requiring physician removal (unlike traditional creams and ointments).
Solution Approach 2:
The formulation combines antifungal agents, antibiotics, anti-inflammatory steroids, and thickening agents into a composite gel system. This composite structure provides multiple therapeutic functions while maintaining optimal rheological properties for both retention and easy removal, eliminating the need for physician intervention.
3Reliability
If multiple applications of antifungal medication are required to treat fungal ear infections, then the treatment can be tailored to the specific infection, but patient compliance decreases and treatment period is prolonged
Solution Approach 1:
The patent incorporates a broad spectrum of active ingredients (antifungals, antibiotics, anti-inflammatories) into a single formulation that provides comprehensive treatment in one application. The sustained-release gel matrix ensures continuous medication delivery over several days, eliminating the need for multiple patient applications and improving compliance while maintaining treatment efficacy.
4Ease of operation
If pure liquid form drugs are used to treat chronic otitis externa, then they are easy to administer, but they egress rapidly and do not reach all infected areas
Solution Approach 1:
The patent modifies the physical state of the medication from liquid to semi-solid gel by adding carboxnymethylcellulose sodium as a thickening agent. This formulation maintains ease of administration through the ear canal while significantly improving retention time and distribution to all infected areas including vertical and horizontal portions of the ear canal that liquid drops cannot reach.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation achieves a high cure rate of up to 100% in 7 days with minimal bacterial resistance by maintaining active ingredients in the ear canal for an extended period, reducing the need for multiple applications and improving patient compliance.
Implementation Method 1
A single-dose otic formulation containing marbofloxacin, terbinafine, and dexamethasone or clotrimazole in a thickened base that maintains viscosity within the ear canal for several days
Data Source
AI summary
The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, antifungal, and an anti-inflammatory in a thick, otic carrier. In one embodiment, the formulation comprises a therapeutically effective amount of active ingredients including a marbofloxacin, terbinafine and/or clotrimazole and dexamethasone.